Quest Diagnostics Pays $13 Million to Settle Illegal Kickback Allegations
By Natalie Weger
Quest Diagnostics paid about $13 million to the Justice Department to settle allegations that it offered healthcare providers and executives illegal kickbacks.
The kickbacks, allegedly paid for by federal healthcare programs, were meant to generate business referrals to Quest, according to the lawsuit.
The clinical laboratory company allegedly provided free entertainment events for executives between July 2013 and August 2022, offering items or services such as free tickets for suite seats at New York Giants games.
The lawsuit alleged that the company then submitted false claims for lab services that Medicare and New York and New Jersey Medicaid paid for.
Along with the settlement, Quest has entered into a five-year federal Corporate Integrity Agreement with the U.S. Department of Health and Human Services Department.
"Although we deny any allegations of wrongdoing or violation of the law, over a year ago, in 2025, we agreed to a settlement with the government to put the matter behind us," the company said.
Write to Natalie Weger at natalie.weger@wsj.com.
(END) Dow Jones Newswires
November 06, 2026 17:47 ET (22:47 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
3 Stocks to Sell and 3 Stocks to Buy for November
3 of the Best Dividend Stocks to Own
The 10 Best Companies to Invest in Now
These Overvalued Stocks Have Plenty of Room to Fall
United States